Marca Mista depositada no INPI em 26/10/2020 por MYR GmbH, processo nº 501591282, nas classes 01, 05, 09, 42, 44. Registro em vigor até 26/10/2030.
| Número do processo | 501591282 |
|---|---|
| Situação | Registro de marca em vigor (Madri) |
| Apresentação | Mista |
| Natureza | Madri Produto/Serviço |
| Data do depósito | 26/10/2020 |
| Data da concessão | 03/03/2022 |
| Vigência até | 26/10/2030 |
| Titular | MYR GmbH |
| UF · País | — · DE |
Chemicals for use in industry and science; peptides substrates for scientific and industrial purposes; oligopeptides; polypeptides; proteins [raw material]; polynucleotides [chemicals for scientific purposes]; oligonucleotides [chemicals for scientific purposes]; nucleic acids; SiRNA molecules; small molecules having a molar mass of 160 to 480 [for scientific purposes].;
Pharmaceutical and veterinary preparations; biological preparations for medical purposes; biological preparations for veterinary purposes; biochemical preparations for medical purposes; biochemical preparations for veterinary purposes; chemical preparations for medical purposes; chemical preparations for veterinary purposes; medicines for medical purposes; medicines for veterinary purposes; pharmaceutical preparations for treating liver diseases and disorders; pharmaceutical products for hepatitis B; pharmaceutical products for hepatitis D; pharmaceutical preparations for dyslipidemia; pharmaceutical preparations for nonalcoholic steatohepatitis [NASH]; pharmaceutical preparations for primary biliary cholangitis [PBC]; pharmaceutical preparations for inflammatory diseases; pharmaceutical preparations for inflammatory diseases inhibiting sodium-taurocholate co-transporting polypeptide [NTCP]; pharmaceutical preparations for the treatment of metabolic diseases; pharmaceutical preparations for the treatment of metabolic diseases inhibiting sodium-taurocholate co-transporting polypeptide [NTCP].;
Scientific, surveying, weighing, measuring apparatus and instruments; apparatus and instruments for scientific research, in particular scientific research in laboratories; data processing apparatus; computers; CDs; DVDs; digital recording media; computer software.;
Scientific and technological services and research and design relating thereto; industrial analysis services; industrial research services; scientific research for medical, chemical, biological, veterinary and pharmaceutical purposes; scientific and technological services and research and design related thereto in the field of hepatitis B; scientific and technological services and research and design related thereto in the field of hepatitis D; scientific and technological services and research and design related thereto in the field of dyslipidemia; scientific and technological services and research and design related thereto in the field of nonalcoholic steatohepatitis [NASH]; scientific and technological services and research and design related thereto in the field of primary biliary cholangitis [PBC]; scientific and technological services and research and design related thereto in the field of inflammatory diseases; scientific and technological services and research and design related thereto in the field of inflammatory diseases inhibiting sodium-taurocholate co-transporting polypeptide [NTCP]; scientific and technological services and research and design related thereto in the field of metabolic diseases; scientific and technological services and research and design related thereto in the field of metabolic diseases inhibiting sodium-taurocholate co-transporting polypeptide [NTCP]; design and development of computer hardware and software; scientific and technological services in the field of preclinical development, in particular related to hepatitis B, hepatitis D, dyslipidemia, nonalcoholic steatohepatitis [NASH], inflammatory diseases, inflammatory diseases inhibiting sodium-taurocholate co-transporting polypeptide [NTCP], primary biliary cholangitis [PBC], metabolic diseases, and metabolic diseases inhibiting sodium-taurocholate co-transporting polypeptide [NTCP]; scientific and technological services in the field of clinical development, in particular related to hepatitis B, hepatitis D, dyslipidemia, nonalcoholic steatohepatitis [NASH], primary biliary cholangitis [PBC], inflammatory diseases, inflammatory diseases inhibiting sodium-taurocholate co-transporting polypeptide [NTCP], metabolic diseases, and metabolic diseases inhibiting sodium-taurocholate co-transporting polypeptide [MVP].;
Medical services; veterinary services; medical and veterinary services, in particular medical analysis in connection with the treatment of individuals; providing information in the medical field, veterinary field and pharmacology; services of health centres; services of clinics (ambulances); therapy services; hygienic and beauty care for human beings and animals.;
Receba um e-mail a cada novo despacho publicado na RPI para o processo 501591282 — exigência, oposição, deferimento, prazo de pagamento — e quando alguém depositar uma marca parecida.
Monitorar esta marca Ver marcas parecidas5 despacho(s) publicado(s) na Revista da Propriedade Industrial.
26.3.1 Um triângulo26.3.18 Triângulos com uma ou mais letras26.3.7 Figuras triangulares com um ou mais ângulos cortados ou arredondados27.5.1 Letras apresentando um grafismo especial27.5.10 Grupos de letras apresentando dimensões diferentes27.5.15 Grupos de letras separadas umas das outras sem que seja por um único espaço29.1.13 Três cores predominantes